Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating light-assisted ex vivo treatment and antiviral strategies for recipients of lungs from HBV-infected donors; recruitment is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hepatitis B Virus (HBV), Lung Transplant Recipient | Phase 4 | Status: RECRUITING